๐ฐ Herbert Boyer News
Page 2 - Herbert Boyer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Herbert Boyer. Real-time updates on events, politics, business and more.
April 5, 2023
How a small Houston biotech company and a giant California-based rival are battling over who developed what may be a revolutionary cure for asthma and allergies.
March 28, 2023
The history of biotechnology shows how humans have been manipulating nature for our benefit for a long timeโand how modern genetic engineering is
March 25, 2023
There is no way you will talk about the Biotech Industry without referring Genentech. They represent the bridge between the past and future of the.........
March 2, 2023
/PRNewswire/ -- GATC Health Corp, a technology company revolutionizing drug discovery and disease prediction using artificial intelligence (AI), announced that...
January 24, 2023
Many genetically modified organisms have traits that would be nearly impossible to develop through traditional breeding.
December 22, 2022
Every revolution rises up against an order in need of reform. For the orphan drug revolution, that order was the pharmaceutical industry of the 1970s.
December 19, 2022
GUS DOES NOT BELIEVE IN GOD. BUT GUS THINKS THAT ANYTHING THAT IS ALIVE SHOULD NOT BE PATENTED. ESPECIALLY BY "AMERICA". THE "NEW" mRNA VACCINE IS A BIT OF AN ARTIFICIAL BASTARD THAT DOES NOT WORK EFFICIENTLY. MEANWHILE THE MEDIA WAS PUSHED TO EXTOLD THE VIRTUES OF THIS VACCINE AND NOTHING ELSE.
November 8, 2022
There are 37 trillion cells that make up the human body. Each of these cells contains the original genetic information from the very first cell. Our DNA is a thousand times smaller than the cell, [...]
October 31, 2022
GENETIC engineering took off in the early 1970s when biochemists Herbert Boyer and Stanley Cohen inserted DNA from one bacterium into another. Organisms thus developed are called genetically modified (GM) or transgenic, where genes have been transferred from one organism to an unrelated organism, e.
July 5, 2022
The European Patent Office (EPO) has been looking again at the need for a grace period in the European Patent Convention. Last month it published the results of a survey that found only a small minority of its users would take advantage of such a mechanism, but also that the lack of a grace period is stopping universities from commercialising some of their research. As a result, Europe may be missing out on lucrative new products, start-ups, and even potential unicorns.